Kingdon Capital Management’s Tonix Pharmaceuticals TNXP Stock Holding History

Kingdon Capital Management’s Portfolio TNXP Stock Details TNXP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Hold	0	–	-$279K	–	135
2017 Q2	–	Hold	0	–	–	–	97
2017 Q1	–	Hold	0	–	–	–	105
2016 Q4	–	Hold	0	–	–	–	120
2016 Q3	–	Hold	0	–	–	–	114
2016 Q2	–	Hold	0	–	–	–	79
2016 Q1	–	Hold	0	–	–	–	84
2015 Q4	–	Hold	0	–	–	–	54
2015 Q3	–	Hold	0	–	–	–	74
2015 Q2	–	Hold	0	–	–	–	83
2015 Q1	–	Hold	0	–	–	–	106
2014 Q4	–	Hold	0	–	–	–	119
2014 Q3	–	Hold	0	–	–	–	122
2014 Q2	–	Hold	0	–	–	–	147
2014 Q1	–	Hold	0	–	–	–	144

Other funds holding TNXP

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

B. Riley Financial Los Angeles, California $434M AUM 751.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Susquehanna International Group

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

A.R.T. Advisors New York $1.79M AUM 57.47% 1-Year Est. Return

Renaissance Technologies

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dimensional Fund Advisors

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Nine Chapters Capital Management Short Hills, New Jersey $45.4M AUM 14.43% 1-Year Est. Return

Oppenheimer & Co

Oppenheimer & Co New York $9.37B AUM 36.4% 1-Year Est. Return